butyl 4-(p-toluenesulfonylaminocarbonylamino)benzoate | 128924-29-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: butyl 4-(p-toluenesulfonylaminocarbonylamino)benzoate
• 英文别名: butyl 4-p-toluenesulfonylaminocarbonylaminobenzoate；butyl 4-[(4-methylphenyl)sulfonylcarbamoylamino]benzoate
• CAS: 128924-29-8
• 化学式: C₁₉H₂₂N₂O₅S
• 分子量: 390.46
• InChiKey: XEXDWZLVDSFVFU-UHFFFAOYSA-N

物化性质

• 密度：
  1.281±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  110
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  对氨基苯甲酸丁酯 、 对甲基苯磺酰异氰酸酯 以 乙腈 为溶剂， 反应 3.08h， 生成 butyl 4-(p-toluenesulfonylaminocarbonylamino)benzoate
  参考文献：
  名称：

  Bis (arylsulfonylaminocarbonylaminobenzoate) compounds and thermosensitive recording materials containing same

  摘要：

  一种具有高白度和抗高温高湿条件下色彩形成的热敏记录材料，在基材表面上形成了热敏着色成像层，包括染料前体、粘合剂和包括化合物(I)的颜色显色剂，以及可选地包括化合物(V)的颜色显色剂。R1、R3=未取代或甲基或氯取代芳基，R2=至少C3的二价有机基团，R4=至少C3的烷基、芳基烷基或芳基氧烷基基团。

  公开号：

  US06677472B2

文献信息

• Thermosensitive recording material and novel color developer compounds
  申请人：OJI PAPER CO., LTD.

  公开号：EP1264707A3

  公开（公告）日：2004-05-19

  Disclosed is a thermosensitive recording material comprising a sheet-shaped support and a thermosensitive recording layer which is formed on at least one surface of the support and comprises a colorless or light-colored dye precursor and a color developer capable of reacting with the dye precursor and inducing color formation therein upon application of heat thereto, the color developer comprising a compound represented by the following formula (I) or analog thereof::The thermosensitive recording material has high sensitivity and can prevent white background portions from coloring and recorded images from decolorizing in an environmental resistance test.

  本发明揭示了一种热敏记录材料，包括一种片状支撑和一种热敏记录层，该热敏记录层形成在支撑的至少一个表面上，并包括一种无色或浅色染料前体和一种能够与染料前体反应并在施加热量后在其中诱导颜色形成的显色剂，其中显色剂包括由以下化学式(I)或其类似物表示的化合物：该热敏记录材料具有高灵敏度，并且可以防止白色背景部分着色和记录图像在环境抗性测试中褪色。
• Bis(arylsulfonylaminocarbonylaminobenzoate) compounds and thermosensitive recording materials containing same
  申请人：Oji Paper Company Limited

  公开号：EP1044824A2

  公开（公告）日：2000-10-18

  A thermosensitive recording material having high whiteness and resistance to color formation under high temperature, high humidity conditions has a thermosensitive colored image-forming layer formed on a substrate sheet and includes a dye precursor, a binder and a color developing agent including a compound of the formula (I) and optionally a compound of the formula (V). R1, R3 = unsubstituted or methyl or chlorine-substituted aryl group, R2 = at least C3 divalent organic group, R4 = at least C3 alkyl, aralkyl or aryloxyalkyl group.

  一种在高温、高湿条件下具有高白度和抗彩色形成能力的热敏记录材料，其热敏彩色图像形成层形成于基片上，包括染料前体、粘合剂和显色剂，其中包括式（I）化合物和可选的式(V)化合物。 R1、R3 = 未取代或甲基或氯取代的芳基，R2 = 至少 C3 的二价有机基团，R4 = 至少 C3 的烷基、芳基或芳氧基烷基。
• Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships
  作者：J. Jeffry Howbert、C. Sue Grossman、Thomas A. Crowell、Brent J. Rieder、Richard W. Harper、Kenneth E. Kramer、Eddie V. Tao、James Aikins、Gerald A. Poore

  DOI：10.1021/jm00171a013

  日期：1990.9

  A series of diarylsulfonylureas with exceptionally broad-spectrum activity against syngeneic rodent solid tumors in vivo is described. Their discovery resulted from a program dedicated to in vivo screening for novel oncolytics in solid tumor models, rather than traditional ascites leukemia models. The structures, oral efficacy, side-effect profile, and mechanism of action of these sulfonylureas appear to be distinct from previously known classes of oncolytics. An extensive series of analogues was prepared to probe structure-activity relationships (SAR), with particular focus on the substituent patterns of each aryl domain. Quantitative analysis of these substituent SARs, using the method of cluster significance analysis, showed the lipophilicity of the substituents to be the dominant determinant of activity. One compound from the series, LY186641 (104, sulofenur), has progressed to Phase I clinical trials as an antitumor drug.
• HOWBERT, J. JEFFRY;GROSSMAN, C. SUE;CROWELL, THOMAS A.;RIEDER, BRENT J.;H+, J. MED. CHEM., 33,(1990) N, C. 2393-2407
  作者：HOWBERT, J. JEFFRY、GROSSMAN, C. SUE、CROWELL, THOMAS A.、RIEDER, BRENT J.、H+

  DOI：——

  日期：——
• EP2995466A1
  申请人：——

  公开号：EP2995466A1

  公开（公告）日：2016-03-16